Stewart Parker is the Senior Advisor and Former CEO of IDRI. Stewart founded Targeted Genetics Corporation (Nasdaq: TGEN) in 1992, a Seattle-based biotechnology company formed to develop gene-based treatments for acquired and inherited disease. She held the position of President and CEO from the company's inception until November of 2008. Prior to founding Targeted Genetics, Stewart held various positions at Immunex Corporation from 1981-1992, ending her tenure there as Vice President, Corporate Development and as President, CEO, and Board Member of Receptech Corporation. Stewart currently serves as a member of the board of directors for several for-profit and non-profit companies including C3 Jian Inc, Oncogenex Technologies Inc, Copper Canyon Press, and the University of Washington College of Arts & Sciences.
Stewart received her BA in Slavic Language and Literature from the University of Washington before completing an MBA in Finance and International Business from the University of Washington.
As we end 2013 and look toward 2014 in global health, we’re reminded that the world is a very fragile place.